作者: B.S. Schmetter , K.K. Habicht , D.L. Lamm , A. Morales , N.H. Bander
DOI: 10.1016/S0022-5347(01)64321-0
关键词:
摘要: AbstractPurpose: Presently there is a lack of effective, noninvasive tests for the detection and monitoring bladder cancer. Measurement fibrin/fibrinogen degradation products in urine has been shown to be useful indicator carcinoma. The objective this study was evaluate AuraTek FDP rapid immunoassay device urinary associated with cancer.Materials Methods: A prospective multicenter conducted compare cytology hemoglobin dipstick cancer 192 patients history cancer.Results: significantly more sensitive (68%) than conventional (34%, p <0.001) or (41%, tumors, particularly low stage grade disease. In subjects invasive disease (T2-T4) test had sensitivity 100%. Specificity 96% ...